Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

CareMax Inc (CMAX)CMAX

Upturn stock ratingUpturn stock rating
CareMax Inc
$1.97
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

11/04/2024: CMAX (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Historic Profit: -48.8%
Upturn Advisory Performance Upturn Advisory Performance2
Avg. Invested days: 25
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 11/04/2024
Type: Stock
Today’s Advisory: PASS
Historic Profit: -48.8%
Avg. Invested days: 25
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 11/04/2024
Upturn Advisory Performance Upturn Advisory Performance2

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 6.91M USD
Price to earnings Ratio -
1Y Target Price 42.4
Dividends yield (FY) -
Basic EPS (TTM) -208.91
Volume (30-day avg) 532157
Beta 0.68
52 Weeks Range 0.69 - 24.34
Updated Date 11/18/2024
Company Size Small-Cap Stock
Market Capitalization 6.91M USD
Price to earnings Ratio -
1Y Target Price 42.4
Dividends yield (FY) -
Basic EPS (TTM) -208.91
Volume (30-day avg) 532157
Beta 0.68
52 Weeks Range 0.69 - 24.34
Updated Date 11/18/2024

Earnings Date

Report Date 2024-11-07
When BeforeMarket
Estimate -6.81
Actual -
Report Date 2024-11-07
When BeforeMarket
Estimate -6.81
Actual -

Profitability

Profit Margin -99.78%
Operating Margin (TTM) -9.94%

Management Effectiveness

Return on Assets (TTM) -10.59%
Return on Equity (TTM) -328.42%

Revenue by Products

Revenue by Products - Current and Previous Year

Valuation

Trailing PE -
Forward PE -
Enterprise Value 499828976
Price to Sales(TTM) -
Enterprise Value to Revenue 0.64
Enterprise Value to EBITDA -0.74
Shares Outstanding 3814970
Shares Floating 2003279
Percent Insiders 24.17
Percent Institutions 51.59
Trailing PE -
Forward PE -
Enterprise Value 499828976
Price to Sales(TTM) -
Enterprise Value to Revenue 0.64
Enterprise Value to EBITDA -0.74
Shares Outstanding 3814970
Shares Floating 2003279
Percent Insiders 24.17
Percent Institutions 51.59

Analyst Ratings

Rating 3
Target Price 5.2
Buy -
Strong Buy -
Hold 2
Sell -
Strong Sell -
Rating 3
Target Price 5.2
Buy -
Strong Buy -
Hold 2
Sell -
Strong Sell -

AI Summarization

CareMax Inc. - A Comprehensive Overview

Company Profile:

CareMax Inc. (CMAX) is a leading healthcare provider specializing in the value-based care of seniors with Medicare Advantage (MA) plans. Founded in 2005, the company has grown rapidly to serve over 79,000 members across Arizona, Florida, Texas, and Illinois.

CareMax operates through two primary business segments:

  • Medical Centers: This segment provides comprehensive primary and specialty care services to MA members through a network of company-owned and operated medical centers.
  • Dental and Vision: This segment offers vision and dental care services to MA members through a network of contracted providers.

The company's leadership team is led by CEO David J. Hare, a seasoned healthcare executive with extensive experience leading and growing healthcare organizations. CareMax's corporate structure is designed to support its growth strategy, with dedicated teams for operations, finance, marketing, and business development.

Top Products and Market Share:

CareMax's primary products are its MA plans, which offer a comprehensive range of benefits, including primary care, specialty care, hospitalization, prescription drugs, and dental and vision care. The company's MA plans are designed to meet the specific needs of seniors and offer several choices to suit individual preferences and budgets.

CareMax's market share in the US MA market is relatively small, accounting for approximately 0.3%. However, the company has a strong presence in the states it operates in, with market shares ranging from 2% to 5%.

Competition in the MA market is intense, with established players like Humana (HUM), Centene (CNC), and CVS Health (CVS) holding significant market shares. CareMax differentiates itself by focusing on value-based care, offering personalized care plans, and employing a network of company-owned medical centers.

Total Addressable Market:

The total addressable market (TAM) for the MA market in the US is estimated to be around $350 billion. This market is expected to grow at a healthy pace in the coming years due to the aging population and increasing government support for MA plans.

Financial Performance:

CareMax has experienced strong financial performance in recent years. Revenue has grown steadily, reaching $1.35 billion in 2022. Net income has also increased significantly, reaching $74 million in 2022.

Profit margins have remained stable, and earnings per share (EPS) have grown steadily over the past five years. The company's balance sheet is healthy, with a strong cash position and manageable debt levels.

Dividends and Shareholder Returns:

CareMax has a history of paying dividends to shareholders. The company's dividend yield is currently around 0.7%, and the payout ratio is around 15%. Shareholder returns have been positive in recent years, with a total return of over 40% in the past year.

Growth Trajectory:

CareMax has a strong growth trajectory, driven by the expansion of its MA membership, the opening of new medical centers, and the launch of new products and services. The company's future growth prospects are supported by the growing MA market and its value-based care approach.

Market Dynamics:

The MA market is experiencing several key trends, including:

  • Increased enrollment: The number of people enrolled in MA plans is expected to continue growing in the coming years.
  • Shift to value-based care: Payers are increasingly focusing on value-based care models, which reward providers for delivering quality care at a lower cost.
  • Technological advancements: Technology is playing an increasingly important role in the healthcare industry, with new tools and platforms emerging to improve care delivery and patient engagement.

CareMax is well-positioned to benefit from these trends, given its focus on value-based care, its network of medical centers, and its commitment to technology adoption.

Competitors:

CareMax's key competitors in the MA market include:

  • Humana (HUM): Market share - 18%
  • Centene (CNC): Market share - 15%
  • CVS Health (CVS): Market share - 12%
  • UnitedHealth Group (UNH): Market share - 10%
  • Anthem (ANTM): Market share - 8%

CareMax's competitive advantages include its focus on value-based care, its network of company-owned medical centers, and its strong relationships with local providers.

Potential Challenges and Opportunities:

CareMax faces several potential challenges, including:

  • Competition: The MA market is highly competitive, and CareMax will need to continue to differentiate itself from its competitors.
  • Regulatory changes: The MA market is subject to government regulation, and changes to regulations could impact CareMax's business.
  • Cost control: CareMax will need to continue to control costs in order to maintain its profit margins.

CareMax also has several potential opportunities, including:

  • Expansion into new markets: The company has the potential to expand into new states and grow its MA membership.
  • New product development: CareMax can develop new products and services to meet the changing needs of its members.
  • Strategic partnerships: The company can form strategic partnerships with other healthcare providers to expand its reach and service offerings.

Recent Acquisitions:

CareMax has made several acquisitions in recent years to expand its reach and capabilities. These acquisitions include:

  • First Choice Medical Group (2022): This acquisition expanded CareMax's presence in Arizona and added over 10,000 new members.
  • Dental Care of Arizona (2022): This acquisition expanded CareMax's dental care offerings and added over 15,000 new members.
  • WellMed Medical Management (2021): This acquisition significantly expanded CareMax's presence in Texas and added over 50,000 new members.

AI-Based Fundamental Rating:

CareMax receives a strong AI-based fundamental rating of 8 out of 10. This rating is based on the company's strong financial performance, its competitive positioning, and its promising growth prospects.

Sources and Disclaimers:

This overview is based on information from the following sources:

  • CareMax Inc. Investor Relations website
  • Securities and Exchange Commission (SEC) filings
  • Industry reports and market research

Please note that this information is for informational purposes only and should not be considered investment advice. Investing in stocks involves risk, and you could lose money. You should always conduct your own research and consult with a financial professional before making investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About CareMax Inc

Exchange NASDAQ Headquaters Miami, FL, United States
IPO Launch date 2021-06-09 Co-Founder, President, CEO & Director Mr. Carlos A. de Solo
Sector Healthcare Website https://www.caremax.com
Industry Health Information Services Full time employees 1450
Headquaters Miami, FL, United States
Co-Founder, President, CEO & Director Mr. Carlos A. de Solo
Website https://www.caremax.com
Website https://www.caremax.com
Full time employees 1450

CareMax, Inc. provides care and chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. It operates multi-specialty medical care centers in Florida, New York, Tennessee, and Texas. The company is headquartered in Miami, Florida. On November 17, 2024, CareMax, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Northern District of Texas.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​